公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Aytu BioPharma Inc is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. It has single operating segment. Its product portfolio includes EXXUA, ADHD Portfolio, Pediatric Portfolio, and Other. Majority of revenue comes from ADHD Portfolio. It has presence in United States.
公司地址 7900 East Union Avenue, Suite 920, Denver, CO, USA, 80237
電話號碼 +1 720 437-6580
傳真號碼 --
公司網頁 https://www.aytubio.com
員工數量 76
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Joshua R. Disbrow Director and Chief Executive Officer 美元 608.15K 22/10/2026
Mr. Jarrett T. Disbrow Chief Business Officer 美元 398.14K 22/10/2026
Mr. Ryan J. Selhorn Chief Financial Officer, Principal Accounting Officer, Corporate Secretary and Treasurer 美元 432.46K 22/10/2026
Mr. Greg Pyszczymuka Chief Commercial Officer 美元 434.30K 22/10/2026
 
董事會成員
董事會 職務 更新日期
Ms. Vivian H. Liu Independent Director 22/10/2026
Mr. Joshua R. Disbrow Director and Chief Executive Officer 22/10/2026
Mr. Carl C. Dockery Independent Director 22/10/2026
Mr. John A. Donofrio, Jr Chairman of the Board 22/10/2026
Mr. Abhinav Jain Independent Director 22/10/2026
 
所屬ETF (更新日期: 10/10/2026 03:18)
代號 名稱 佔比% ▼ 持有日期
DFSUDimensional US Sustainability Core 1 ETF0.04%30/09/2026
DFASDimensional US Small Cap ETF0.04%30/09/2026
DFACDimensional US Core Equity 2 ETF0.04%30/09/2026
DCORDimensional US Core Equity 1 ETF0.02%24/09/2026
ITOTiShares Core S&P Total US Stock Mkt ETF<0.000001%06/03/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.